• RegMed XB 2022 Annual Meeting

    RegMed XB 2022 Annual Meeting

    The fourth RegMed XB’s Annual Meeting was held in the Philips Stadion in Eindhoven on 6 and 7 July. They were successful and exciting days, marked by the positive vibe of interaction.
  • 33 million euros from National Growth Fund for RegMed XB Pilot factory for regenerative medicine

    33 million euros from National Growth Fund for RegMed XB Pilot factory for regenerative medicine

    The urgency is high in the field of regenerative medicine. Promising therapies are in the pipeline from the lab to the patient, but a good infrastructure is needed to make this possible.
  • A first step towards personalized prediction of thrombus formation risk and thromboembolism with regard to ex-vivo perfusion of organs such as the heart.

    A first step towards personalized prediction of thrombus formation risk and thromboembolism with regard to ex-vivo perfusion of organs such as the heart.

    Mohammad Rezaeimoghaddam and Frans van de Vosse have published a paper with the title ”Continuum modeling of thrombus formation and growth under different shear rates” in the Journal of Biomechanics.
  • The BioLIVE and Pharma IT & Digital Health Expo

    The BioLIVE and Pharma IT & Digital Health Expo

    Interested in showcasing your BioPharma or Digital Health technologies to the Japanese audience?
  • FIRST participates in 1.8 million seed investment for the discovery of two new drugs for heart failure

    FIRST participates in 1.8 million seed investment for the discovery of two new drugs for heart failure

    River BioMedics, a drug discovery company using advanced 3D human cardiac models, today announced the closure of a 1.8 million Euro seed funding round to progress its research and innovation programs for cardiovascular disease targets and compounds.
  • Realisation of national Pilot factory for regenerative medicine has started

    Realisation of national Pilot factory for regenerative medicine has started

    RegMed XB has received the first subsidy of 23 million euros from the Ministry of Economic Affairs and Climate Policy. This is the start of the realization of the national pilot factory for regenerative medicine after the Dutch cabinet decided on 9 April this year to fund the National Growth Fund proposal of RegMed XB.
  • RegMed XB partner LUMC receives 100 million euros for research for stem cell based therapies

    RegMed XB partner LUMC receives 100 million euros for research for stem cell based therapies

    Leiden University Medical Centre (LUMC), the DanStem Institute at the University of Copenhagen and the Murdoch Children's Research Institute in Melbourne will jointly receive 300 million euros from the Novo Nordisk Foundation.
  • The Influence of OAT1 Density and Functionality on Indoxyl Sulfate Transport in the Human Proximal Tubule

    The Influence of OAT1 Density and Functionality on Indoxyl Sulfate Transport in the Human Proximal Tubule

    Learn more on what promises to be a new step in kidney-related research...
  • Ten steps to investigate a cellular system with Mathematical modeling

    Ten steps to investigate a cellular system with Mathematical modeling

    Jasia King and Kerbaï Saïd Eroumé of MERLN Institute of Maastricht University have published the article “Ten steps to investigate a cellular system with mathematical modeling” in the scientific journal PLOS computational modeling.
  • Why Definitions Matter and Why We May Need One for Embryo-Like Structures

    Why Definitions Matter and Why We May Need One for Embryo-Like Structures

    Think of a cube. What is its size? What is its color? What is the structure of its surface like? Is the cube solid or hollow? Is it tiny or massive? Transparent or opaque?
  • Diabetes FondsDiabetes Fonds
  • Leids Universitair Medisch CentrumLeids Universitair Medisch Centrum
  • Provincie UtrechtProvincie Utrecht
  • RijksoverheidRijksoverheid
  • Health HollandHealth Holland
  • Maastricht UMC+Maastricht UMC+
  • Provincie LimburgProvincie Limburg
  • TU/eTU/e
  • NierstichtingNierstichting
  • Provincie Noord-BrabantProvincie Noord-Brabant
  • Universiteit LeidenUniversiteit Leiden
  • LeidenLeiden
  • Stichting DONStichting DON
  • ReumaNederlandReumaNederland
  • Maastricht UniversityMaastricht University
  • UMC UtrechtUMC Utrecht
  • Utrecht UniversityUtrecht University
  • KU LeuvenKU Leuven
  • VIBVIB
  • HartstichtingHartstichting
  • 300Microns300Microns
  • Access2boneAccess2bone
  • Chemelot InSciTeChemelot InSciTe
  • Cyto smartCyto smart
  • Dutch CardioVascular AllianceDutch CardioVascular Alliance
  • Flanders State of the ArtFlanders State of the Art
  • FUJIFILMFUJIFILM
  • GalápagosGalápagos
  • HCM MedicalHCM Medical
  • Kuros BiosciencesKuros Biosciences
  • LifeTec GroupLifeTec Group
  • MateriomicsMateriomics
  • MimetasMimetas
  • Ministerie van Economische Zaken en KlimaatMinisterie van Economische Zaken en Klimaat
  • Ministerie van Onderwijs Cultuur en WetenschapMinisterie van Onderwijs Cultuur en Wetenschap
  • Ministerie van Volksgezondheid, Welzijn en SportMinisterie van Volksgezondheid, Welzijn en Sport
  • NcardiaNcardia
  • Nestegg BiotechNestegg Biotech
  • NTrans TechnologiesNTrans Technologies
  • Ostheo PharmaOstheo Pharma
  • Provincie Zuid-HollandProvincie Zuid-Holland
  • ScinusScinus
  • Starfish InnovationsStarfish Innovations
  • StentitStentit
  • SupraPolixSupraPolix
  • veldlaserveldlaser
  • VisualsonicsVisualsonics
  • XeltisXeltis

Information for

Contact information

  • Stichting REGMED XB
  • Minderbroedersberg 4-6, 6211 LK  Maastricht
  • This email address is being protected from spambots. You need JavaScript enabled to view it.

Connect with us

Copyright © 2021 RegMed XB. All rights reserved
Realisation & design by Joomlapartner